对比增强锥光束乳腺CT、MRI与乳腺X线摄影对乳腺癌特征描述的比较
回顾性纳入2017年1月至2022年7月间207例患者的214个乳腺恶性病灶,比较CE-CBBCT、MRI与乳腺X线摄影参照BI-RADS描述乳腺癌特征的一致性。CE-CBBCT与MRI在病灶类型识别上几乎完全一致(Kappa=0.865),与乳腺X线摄影仅中等一致(Kappa=0.287);CE-CBBCT在肿块与非肿块强化特征描述上与MRI高度一致,NCE-CBBCT在钙化上与乳腺X线摄影高度一致,提示CE-CBBCT可综合形态学、血流动力学与钙化特征。
要点
- CE-CBBCT与MRI在病灶类型识别上几乎完全一致(Kappa=0.865),与乳腺X线摄影仅中等一致(Kappa=0.287)。
- CE-CBBCT与MRI在肿块(Kappa=0.752-0.824)和非肿块强化(Kappa=0.702-0.729)特征描述上高度一致。
- NCE-CBBCT与乳腺X线摄影在钙化描述上高度一致(Kappa=0.717-0.777)。
核心结论
- CE-CBBCT在肿块和非肿块强化特征描述上与MRI高度一致,在钙化上与乳腺X线摄影高度一致,提示CE-CBBCT可综合形态学、血流动力学与钙化特征,相应描述词有可行性用于描述CE-CBBCT乳腺癌特征。
研究设计与样本
- 回顾性研究,纳入2017年1月至2022年7月间术前接受CE-CBBCT、MRI和乳腺X线摄影的乳腺癌患者207例,共214个恶性病灶;三名经验丰富的放射科医生参照BI-RADS独立判读各模态图像,洗脱期4周,其中一名医生在初次评估4周后复查CE-CBBCT图像;以多数报告为基础用Cohen's Kappa计算跨模态一致性,用Fleiss和Cohen's Kappa分别评估阅片者间和阅片者内一致性。
关键影像表现/征象
- CE-CBBCT与MRI在病灶类型识别上几乎完全一致(Kappa=0.865,95%CI:0.802-0.928),与乳腺X线摄影仅中等一致(Kappa=0.287,95%CI:0.205-0.369)。
- CE-CBBCT与MRI在肿块特征描述上高度一致(Kappa=0.752-0.824),在非肿块强化特征描述上高度一致(Kappa=0.702-0.729)。
- NCE-CBBCT与乳腺X线摄影在钙化描述上高度一致(Kappa=0.717-0.777)。
诊断标准与关键数值
- CE-CBBCT与MRI病灶类型识别一致性Kappa=0.865(95%CI:0.802-0.928),与乳腺X线摄影Kappa=0.287(95%CI:0.205-0.369)。
- CE-CBBCT与MRI肿块特征描述一致性Kappa=0.752-0.824,非肿块强化特征描述一致性Kappa=0.702-0.729。
- NCE-CBBCT与乳腺X线摄影钙化描述一致性Kappa=0.717-0.777。
- CE-CBBCT判读的阅片者间一致性Kappa=0.611-0.738,阅片者内一致性Kappa=0.757-0.887。
- 不同一致性水平间的影像因素差异无统计学意义(所有p>0.05)。
临床应用与阅片要点
- 作者认为CE-CBBCT可综合形态学、血流动力学和钙化特征,应用MRI和乳腺X线摄影的BI-RADS描述词解读CE-CBBCT图像具有临床可行性。
- CE-CBBCT与MRI在肿块和非肿块强化描述上高度一致,与乳腺X线摄影在钙化描述上高度一致,阅片时可参照相应模态的BI-RADS词典进行描述。
- CE-CBBCT与乳腺X线摄影在病灶类型识别上仅中等一致(Kappa=0.287),跨模态解读时需注意这一差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To compare the consistency of contrast-enhanced cone-beam breast CT (CE-CBBCT), MRI and mammography regarding characterization of breast cancer.
METHODS: In this retrospective study, patients with breast cancer who underwent preoperative CE-CBBCT, MRI, and mammography between January 2017 and July 2022 were enrolled. Three experienced radiologists independently interpreted the characteristics of breast lesions on each imaging mode referring to BI-RADS, with a 4-week wash-out period. One of the three radiologists reviewed the CE-CBBCT images 4 weeks after the initial evaluation. Cross-modality consistency was calculated by Cohen's Kappa based on majority report. Inter-and intra-reader agreement were assessed using Fleiss and Cohen's Kappa, respectively. The association between imaging factors and consistency levels was analyzed using chi-square and Mann-Whitney U test.
RESULTS: A total of 214 malignant lesions identified in 207 patients were enrolled. CE-CBBCT showed almost perfect agreement with MRI on lesion type identification (Kappa = 0.865, 95% CI: 0.802-0.928), but fair agreement with mammography (Kappa = 0.287, 95% CI: 0.205-0.369). CE-CBBCT showed substantial agreement on characterization with MRI for both mass (Kappa = 0.752-0.824) and non-mass enhancement (NME) (Kappa = 0.702-0.729), and non-contrast-enhanced CBBCT (NCE-CBBCT) showed substantial agreement with mammography for calcification (Kappa = 0.717-0.777). Inter- (Kappa = 0.611-0.738) and intra-reader (Kappa = 0.757-0.887) agreement were substantial on CE-CBBCT interpretation. There was no statistically significant difference in imaging factors between different consistency levels (all p > 0.05).
CONCLUSIONS: CE-CBBCT showed high consistency on mass and NME characterization with MRI, and on calcification with mammography, indicating that CE-CBBCT could combine morphology, hemodynamic and calcification features, and the corresponding descriptors have the feasibility to describe CE-CBBCT characteristics of breast cancer.
KEY POINTS: Question Contrast-enhanced cone-beam breast CT (CE-CBBCT) is widely used in the diagnosis and assessment of breast cancer, but there is no standardized lexicon for image interpretation. Findings CE-CBBCT showed high consistency and comparable reproducibility with MRI and mammography for characterizing breast cancer lesions. Clinical relevance The findings prove that CE-CBBCT could combine morphology, hemodynamic, and calcification features and provide support for the feasibility of applying the BI-RADS descriptors of MRI and mammography to interpret contrast-enhanced cone-beam breast CT images in clinic.
引用
- Ma Y, Wang Y, Zhang Y, et al. Comparison of contrast-enhanced cone-beam breast CT, MRI, and mammography for breast cancer characterization. Eur Radiol. 2025. PMID: 40240554. doi:10.1007/s00330-025-11568-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。